Search results
...STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or...
Morningstar· 4 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma ...
...BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE...
Morningstar· 5 days agoFood and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative ...
Rituximab Tied to Increased Infection Risk in RRMS
Medscape· 7 days agoThe B-cell–depleting treatment rituximab was associated with a twofold increased risk for infection in RRMS, regardless of treatment duration or whether the patient had received other DMTs first.
Sjogren's Syndrome
Health· 7 hours agoRelated Conditions Due to inflammation and immune changes in Sjogren’s, about 5% of people with Sjogren’s syndrome eventually develop a type of blood...
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has approved Amgen’s BLINCYTO (blinatumomab) for...
Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto
Morningstar· 5 days agoThe biotechnology company on Friday said the approval is aimed at adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-< ...
Atezolizumab Consolidation Impresses in High-Risk DLBCL
MedPage Today· 6 days agoPostchemotherapy consolidation with atezolizumab (Tecentriq) led to a surprisingly high 2-year...
Epstein-Barr virus: How does a common infection trick the immune system into attacking the brain in...
Medical Xpress· 2 hours agoWhile treatments for MS have improved over the years, there's still no cure. This is largely because researchers still don't fully understand what goes wrong in the immune system to cause MS ...
Could auto-antibodies be linked to severe COVID-19?
Medical Xpress· 1 hour agoEven though COVID-19 manifests as a mild and short-lived disease in most people, some suffer extremely severe symptoms; in the worst cases, these patients die due to complications such as respiratory ...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 2 days agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
